Brown Rudnick LLP advised Eliem Therapeutics on the deal. Eliem Therapeutics Inc. recently closed on a $60-million Series B financing. Eliem is a clinical-stage biotechnology company...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here